Basit öğe kaydını göster

dc.contributor.authorAkovali, Burak
dc.contributor.authorDemirci, Emre
dc.contributor.authorNematyazar, Jamal
dc.contributor.authorKabasakal, Levent
dc.contributor.authorOcak, Meltem
dc.contributor.authorSahin, Onur Erdem
dc.date.accessioned2021-03-05T12:16:52Z
dc.date.available2021-03-05T12:16:52Z
dc.date.issued2016
dc.identifier.citationDemirci E., Sahin O. E. , Ocak M., Akovali B., Nematyazar J., Kabasakal L., "Normal distribution pattern and physiological variants of Ga-68-PSMA-11 PET/CT imaging", NUCLEAR MEDICINE COMMUNICATIONS, cilt.37, ss.1169-1179, 2016
dc.identifier.issn0143-3636
dc.identifier.otherav_ac6728c6-8392-4543-a322-807a0c48c47a
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/115056
dc.identifier.urihttps://doi.org/10.1097/mnm.0000000000000566
dc.description.abstractPurpose(68)Ga-PSMA-11 is a novel PET tracer suggested to be used for imaging of advanced prostate cancer. In this study, we aimed to present a detailed biodistribution of Ga-68-PSMA-11, including physiological and benign variants of prostate-specific membrane antigen (PSMA) imaging.Materials and methodsWe carried out a retrospective analysis of 40 patients who underwent PSMA PET/computed tomography (CT) imaging and who had no evidence of residual or metastatic disease on the scans. In addition, 16 patients who underwent PSMA PET/CT imaging with any indication other than prostate cancer were included in the study to evaluate physiological uptake in the normal prostate gland. The median, minimum-maximum, and mean standardized uptake value (SUV) values were calculated for visceral organs, bone marrow and lymph nodes, and mucosal areas. Any physiological variants or benign lesions with Ga-68-PSMA-11 were also noted.Results(68)Ga-PSMA-11 uptake was noted in the kidneys, parotid and submandibular glands, duodenum, small intestines, spleen, liver, and lacrimal glands, and mucosal uptake in the nasopharynx, vocal cords, pancreas, stomach, mediastinal blood pool, thyroid gland, adrenal gland, rectum, vertebral bone marrow, and testes. Celiac ganglia showed slight Ga-68-PSMA-11 uptake in 24 of 40 patients without the presence of any other pathologic lymph nodes in abdominal and pelvic areas. Variable uptake of Ga-68-PSMA-11 was observed in calcified choroid plexus, a thyroid nodule, an adrenal nodule, axillary lymph nodes and celiac ganglia, occasional osteophytes, and gallbladder. The patient group with PSMA PET/CT for indications other than prostate cancer (n=16) showed a slight radiotracer uptake in normal prostate gland (SUVmax: 5.51.6, range: 3.5-8.3).ConclusionThis study shows normal distribution pattern, range of SUVs, and physiological variants of Ga-68-PSMA-11. In addition, several potential pitfalls were documented to prevent misinterpretations of the scan.
dc.language.isoeng
dc.subjectNükleer Tıp
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectRADYOLOJİ, NÜKLEER TIP ve MEDİKAL GÖRÜNTÜLEME
dc.titleNormal distribution pattern and physiological variants of Ga-68-PSMA-11 PET/CT imaging
dc.typeMakale
dc.relation.journalNUCLEAR MEDICINE COMMUNICATIONS
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume37
dc.identifier.issue11
dc.identifier.startpage1169
dc.identifier.endpage1179
dc.contributor.firstauthorID82066


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster